Entities
LogoName Σ Employees
InnaVirVax InnaVirVax

InnaVirVax is a French privately-owned biopharmaceutical company dedicated to the development of a cutting edge discovery in the field of therapy/prevention and prognostic of AIDS and HIV infection, other infectious diseases, and cancer therapies. InnaVirVax is developing product candidates resulting from a beakthrough discovery, made at Inserm, the French Medical research council, the AP-HP, the largest hospital in Europe, and University Pierre et Marie Curie in Paris. Based on a new paradigm (i.e. the understanding of the mechanism responsible for the decline of the CD4+ T lymphocytes (CD4) in HIV-infected patients), the products currently developed by InnaVirVax will allow the …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 0
Cell-Free Technology Ltd. Cell-Free Technology Ltd.

We build biocomputers. We are hiring.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 0 0 0
Desktop Genetics Desktop Genetics

Powering the genome editing revolution with AI-driven design and analysis for cell therapy and drug discovery. Desktop Genetics is an international company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by the real-world impact of CRISPR technology. We have invested four years developing our core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers our flagship DESKGEN CRISPR Library …

Type: Startup Activities: biotech deeptech Technologies: Generative A.I. A.I. A.I. - Machine Learning Synthetic Biology

0 0 0 0
Nascent Biotech, Inc. Nascent Biotech, Inc.

Nascent’s development approach utilizes the immune system’s innate capabilities and selectivity. Nascent Biotech, Inc. (OTCMKTS:NBIO) is a public company, formed in March 2014, to continue development of Pritumumab, a human monoclonal antibody created by a number of leading scientists who have developed various monoclonal antibodies and cytokine treatments for oncology indications. Pritumumab recognizes a unique and proprietary antigen expressed on the surface of cancer cells and is being developed to treat brain and pancreatic cancers, both unmet clinical needs. NBIO’s clinical premise is that the most effective way to treat disease is to modulate (boost or suppress) the human body’s …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

0 0 0 0
Zippyware Zippyware

[Automatic translation follows] “Health – Education – Digital”: this is Zippyware’s leitmotif. Our mission ? Ensuring that each of us becomes an actor in our own health through interactive solutions. At Zippyware, we are convinced of the need for prevention in public health and the major role of therapeutic education, in particular through multimedia supports. Digital transformation creates tremendous opportunities to enable as many people as possible to take control of their health. Thanks to our unique combination of medical, educational and technological skills, Zippyware offers fun, innovative, efficient e-health solutions that meet the specific needs of users. Our tools …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

0 0 0 0
RGL Research RGL Research

Supporting Healthcare Innovation R.G.L Research is a contract research organization (CRO) providing expertise and reliable support to the pharmaceutical industries for conducting Clinical Trials. Our clients and partners include pharmaceuticals, biotechnologies, startups, academic and government organization. R.G.L Research is providing tailored and quality services to help clients and partners bend the cost and time curve of drug development to deliver new alternative product and innovative treatment to improve patients quality of life. R.G.L Research has vast professional experience and academic knowledge in performing clinical trials in Israel as well as developing health product in diverse therapeutic areas of medicine, in …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 0
iPC H2020 iPC H2020

Giving clinicians the tools and knowledge to create individualized treatment plans for their paediatric cancer patients. Cancer in children is rare but when it happens, clinician prescribed treatment options are not always as clear as one would hope. In fact, on average, only a quarter of oncology patients respond to the drug therapy they receive. There are many reasons for this but evidence shows that a personalized treatment plan or treatment that is based on the patient's fundamental biology could significantly enhance treatment outcomes. As it turns out, the personalized treatment plan can be as complex as the cancer itself …

Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology

1 0 1 0
BASF Pharma Solutions BASF Pharma Solutions

Inspiring Medicines for better Lives BASF Pharma Solutions produces innovative excipients and active ingredients of outstanding quality and performance. With a global team of industry experts and digital solutions, BASF supports its customers in developing efficient, cost-effective and reliable formulations. Equipped with an in-depth understanding of multiple technologies and applications, we have the knowledge and resources to make pharmaceutical drug delivery and the manufacturing of drugs and biologics safer and more sustainable. We create solutions for Biopharma, Parenteral, Oral, Solubilization and Topical applications and are also a leading supplier of selected APIs such as ibuprofen, L-menthol and Omega-3. About BASF …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

1 0 1 0
Miravas Miravas

Miravas is an innovative medical devices start up in varicose veins treatment Soon a new device for the treatment of venous disease in medical office setting, with combination of two complementary techniques, steam and radiofrequency Varicose veins treatment, Medical devices, and Thermal ablation

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

0 0 0 0
Aerogabs Aerogabs

Aerogabs is a consulting service for Entrepreneurs and Small & Medium Business. We boost your Company Performance by designing a Culture of Innovation. We have over 15 years of experience with a strong expertise in high-tech industries such as aerospace and medical devices. We offer 3 solutions: 1-Singularity - understands the dynamic of your territory and then adapt your posture in order to maximize your customer benefits. 2-Strategy - leverages your customer benefits by fully exploiting your potential and reducing the competitive threats. 3-Adocacy - assists you in the implementation of your actionnable plan to boost your venture performance. Please …

Type: Startup Activities: healthtech deeptech spacetech Consulting constructiontech entrepreneurship martech Technologies: Synthetic Biology

0 0 0 1
Sunogel Inc Sunogel Inc

Aiming at perfect skin regeneration MORE than 100 million patients develop scars from elective surgeries each year in developed countries alone.Sunogel is primarily directed toward the development of novel and regenerative therapeutics. At Sunogel, we investigate, incorporate and innovate functional three-dimensional scaffolds that can unlock the power of regeneration for damaged tissues, especially skin regeneration.

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

0 0 0 1
Bioharmony Therapeutics Bioharmony Therapeutics

At Bioharmony Therapeutics, we are developing nontraditional antimicrobial therapeutics by exploiting millions of years of phage-bacteria evolution. Our focus is on targeting infectious diseases caused by multidrug-resistant (MDR) Gram-negative bacteria. Our primary therapeutic indication is for Acinetobacter baumannii skin and wound infections.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 1
Push4m Push4m

[Automatic translation follows] Smart muscles for robotics & exoskeletons Created in 2016, Push4m is a deeptech which patented, after 5 years of R&D, biomimetic muscle, a component which imitates the swelling of human muscle and dramatically improves the efficiency of exoskeletons and robots/cobots. This new generation universal actuator allows self-adaptation to the resisting torque by multiplication of the motor torque or its speed. Through this slow motion, it allows the robotic machine to adapt to its environment and to the operator, in complete safety. And not the other way around as is currently the case. This significantly reduces the energy …

Type: Startup Activities: deeptech Industry 4.0 manufacturing transporttech Technologies: Robotics 3D Printing A.I. Bio sourced materials IoT Synthetic Biology

4 0 4 1
CardioScale Ltd. CardioScale Ltd.

CardioScale is an Israeli medical device start-up founded 2012, pursuing a novel patent applied diagnostic for early detection of cardiovascular deterioration in various patients of heart failure and shock.

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

0 0 0 1
Galactica Biotech Galactica Biotech

Galactica Biotech provides a drug repurposing method to identify novel applications for molecules in the market and in development for major and orphan diseases, reducing risk for patients and time and cost for companies. Our Mission With our specialized knowledge we are targeting to set new standards in the pharmaceutical industry adding value to old drugs and contributing to the health of people. Drug Discovery, Molecule characterization, Drug repurposing, and Novel compound applications

Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

0 0 0 1
IDEABATIC IDEABATIC

SMILE- Smart last-mile Cooling System Reach out to every one however difficult the journey is. IDEABATIC is an award-winning social enterprise solving critical last-mile cold chain issues globally. IDEABATIC has developed a last-mile cooling system called SMILE (SMart last-mILE cooling system) that eliminates error and reduces spoilage in temperature-sensitive substances such as vaccines and bio-products. SMILE is freeze-free and fail-safe. It keeps vaccines and bio-products at between 2 and 8 degrees for 3 to 6 days during use without electricity. SMILE has been iterated, tested and field-proven. With the situation of the current pandemic, the logistics for vaccine delivery and …

Type: Startup Activities: transporttech Technologies: Synthetic Biology

1 0 0 1
Algobiotech Algobiotech

[Automatic translation follows] Specializing in the valorization of microalgae, Algobiotech is involved in the selection of new strains and the extraction of molecules of interest until their exploitation in cosmetic, food supplement and therapeutic applications. Algobiotech aims to develop and market innovative products derived from microalgae for the aforementioned applications. Through its membership of GENOPOLE, the leading French bio cluster in biotechnology, Algobiotech benefits from a very favorable environment for finding the right scientific and institutional partners to develop its R&D program around the identification and validation of the biological activities of molecules derived microalgae. Drawing on its intellectual property, …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 1
PLANTEDIT PLANTEDIT

Our mission is to produce non-transgenic, regulatory free, sustainable, consumer oriented genome edited plant products. PLANTeDIT is the first biotech company dedicated to use patented next generation genome editing tools CRISPR/Cas9 RNPs® from our key collaborator Toolgen (http://toolgen.com/?lang=en) with our transformation technology for efficient direct delivery and swift regeneration of genome edited plants. Our mission is also to revolutionize plant transformation technology with our innovative, universal, cost effective, swift transformation system applicable to broad a range of crop species for direct delivery of genome editing tools. Further, PLANTeDIT aims to develop highly pure mammalian protein and human drugs at cost …

Type: Startup Activities: biotech deeptech agritech Technologies: Synthetic Biology

0 0 0 1
Scaled Biolabs Inc. Scaled Biolabs Inc.

Working at the frontier of microfluidics, automation and machine learning to accelerate cell-based medicines. Scaled Biolabs accelerates the discovery and development of complex cell-based medicines, such as stem cell therapies and cancer immunotherapies. Their full stack optimization engine reduces complexity and time to market, by leveraging high-throughput, micro-scale cell culture, automation, and deep data insight. It also powers internal, grant funded programs such as developing a new gold standard for manufacturing dopaminergic neurons to treat Parkinson’s disease. Microfluidics, Biomedical R&D, Bioreactor, Single-cell Biology, Bioengineering, Stem Cells, Tissue Engineering, Cell Culture, Cell-based Assays, machine learning, and computer vision

Type: Startup Activities: biotech deeptech Technologies: A.I. - Image Processing A.I. - Machine Learning A.I. Synthetic Biology

0 0 0 1
 Virtue Health Virtue Health

Virtue is a digital therapeutics company developing new approaches to treat and prevent age-related diseases. health and health tech

Type: Startup Activities: healthtech Technologies: Synthetic Biology

0 0 0 1
Happineo Happineo

[Automatic translation follows] A psychologist who understands you, anywhere, anytime Happineo offers consultations from qualified psychologists from home by telephone and messages. Confidential and simple, our service allows you to start quality therapeutic monitoring very quickly. Health, Well-being, Psychology, occupational health, and psychosocial risks

Type: Startup Activities: healthtech Technologies: Synthetic Biology

0 0 0 1
Unooc Unooc

[Automatic translation follows] The ambition of the Unooc.fr site is to support pharmacists on the Internet and to guarantee Internet users a purchase from a French pharmacy approved by the government. + For pharmacists: increased visibility, geolocation, highlighting their advice and offers. + For French people: buy safely and at the best price. In one click, Unooc allows you to find: - Drugs, - Homeopathy, - Beauty products, - Baby products, etc. More than 50,000 references from around fifty French partner pharmacies. http://www.Unooc.fr/ Health, Internet, E-Commerce, and Search Engine

Type: Startup Activities: e-commerce healthtech Technologies: Synthetic Biology

1 1 0 1
DOQBOARD DOQBOARD

We facilitate collaboration in observational research to support clinical care quality development. 🎯 DOQBOARD is a collaborative, intuitive, and secure platform dedicated to observational Research. It allows researchers, healthcare facilities, research groups, and healthcare industries to develop their knowledge by conducting studies and registries more simply and efficiently. It is GDPR compliant and hosted in France 🇫🇷 in an ISO27001 environment certified for health data hosting. 🔒 To know more, visit our website at https://www.doqboard.com or contact us at contact@doqboard.com. Recherche clinique, Études cliniques, Outil de centralisation de projets cliniques, Solution de gestion d'études cliniques pour médecins, Conception de formulaire …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

0 0 0 1
The Care Machine Ltd The Care Machine Ltd

Helping you scale-up your ideas and create a resilient business with compelling products that will change people's lives Our mission is to produce bespoke solutions for you by combining our unique engineering and science expertise with our business knowledge, project management and media engagement know-how. From advice on funding streams, to design and manufacture processes, to full project management of your idea, we can help you realise your goals and get your product where it needs to be; with the patient. Unlike other B2B consultancies, The Care Machine works in partnership with our medtech clients. We have created an adaptive …

Type: Startup Activities: healthtech deeptech govtech Technologies: Synthetic Biology

5 0 2 1
Revolve Biotechnologies, Inc. Revolve Biotechnologies, Inc.

Designing novel proteins, enzymes, and antibodies is limited by the problem of generating and screening vast mutational sequence space. Revolve addresses this problem with our patented library generation platform producing custom DNA libraries with unparalleled efficiency. The company has developed an ultra-affinity antibody discovery engine based on this library platform and has a pipeline of protein products in development. Custom mutagenesis libraries, Protein Engineering, Protein Libraries, and Antibody Engineering

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 1
ELSALYS BIOTECH ELSALYS BIOTECH

Innovative medicines to address haemato-oncology related life-threatening and rare diseases ElsaLys Biotech is a specialty pharmaceutical company, part of the Mediolanum Farmaceutici Spa group, focused on innovative medicines to address haemato-oncology related life-threatening and rare diseases. Following strategic acquisitions and targeted developments, ElsaLys is establishing an immunotherapeutic portfolio focused on niche specialty pharmaceuticals to answer unmet medical needs. Our commitment is to offer essential drugs meeting Public Health needs. Founded in 2013, ElsaLys Biotech is located in the heart of the European cluster Lyon Biopole, in Lyon, France. Anticorps thérapeutiques, Anticorps monoclonaux, Therapeutic antibodies, Monoclonal antibodies, ophtalmologie, immune microenvironment, vascular …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

7 3 1 1
AFFICHEM AFFICHEM

[Automatic translation follows] Posterem is a medicinal chemistry company that develops innovative molecules for therapeutic purposes against Cancer and Hearing Loss, as well as innovative active ingredients in the field of dermo-cosmetics. Posterm is a medicinal chemistry company which develops innovative therapeutic molecules against Cancer and Hearing Loss, as well as innovative active ingredients in the field of dermo-cosmetics.

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 1
Inneolab Inneolab

[Automatic translation follows] Designs products that meet user expectations and reveal company values. Are you in charge of the product offering, do you want to improve sales and limit the risks of commercial failure? An essential point A product can be functional, priced consistent with its market, and yet sell poorly or receive poor reviews. Beyond the function, the product must meet customer expectations. If it does not inspire desire, if it does not inspire confidence, if it does not respond to unsaid things more subtle than function, buyers will turn towards the competition. Two mistakes to avoid Don’t ask …

Type: Startup Activities: uxtech Technologies: Synthetic Biology

8 4 5 1
Incuvers Incuvers

Visualize, Connect, and Explore Every Moment of Cellular Research. Incuvers is a hardware + software company developing live cell imaging incubators for cellular researchers. Our flagship product, IRIS (Incuvers Real-time Imaging System) is the most advanced and affordable system for cell culture incubation. Combining hypoxic incubation, live cell imaging, and cloud computing, IRIS lets researchers capture time lapse videos of their entire experiments and monitor them live from anywhere, without ever taking them out of the incubator. The Incuvers mission is to “Visualize, connect, and explore every moment of cellular research”.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 1
Medica Media Medica Media

Medica Media provides print, web-based and mobile media solutions for medical professionals. Written by doctors for doctors. Makers of PocketDr. PocketDr is the must-have app for all junior doctors with on-call responsibilities. It is an aide-memoire for the things you know - but may not recall quickly in the dead of night with constant bleeps and distractions. Succinct. Pre-digested info. When you need it. Contents include: - Checklists for assessment of the deteriorating patient. Be prepared for any NEWS call: Hypoxia, Tachycardia, Hypotension, low GCS. - Checklists for management of 21 acute medical conditions including: ACS, AF, Asthma, Delerium, Hyperkalaemia, …

Type: Startup Activities: healthtech IT Services Technologies: Synthetic Biology

10 2 9 1
Disease Diagnostic Group, Inc Disease Diagnostic Group, Inc

Disease Diagnostic Group, Inc is focused on screening, tracking, and diagnosing highly infectious or neglected tropical diseases through portable and reusable devices. Medical Device Design, Malaria, Infectious Disease, and Diagnostics

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

2 1 0 1
TRIANNI, Inc an AbCellera Company TRIANNI, Inc an AbCellera Company

Exceptional Human Antibody Discovery Technology Trianni, Inc. is a biotech company specializing in human antibody discovery platform technology. We offer the leading in vivo platform enabling efficient discovery of fully-human monoclonal antibodies. The Trianni Mouse offers biologic drug discoverers a best-in-class solution for the isolation of therapeutic antibody candidates. Benefits over older conventional mouse immunization + humanization approaches include superior lead panels with respect to potency and diversity along with speed to the clinic and lower operating costs. We aim to make Trianni’s premium technology available to any Pharma or Biotech company engaged in antibody discovery by offering flexible licenses …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 1
NanoGenics NanoGenics

Nanogenics is an innovative, research-based biotechnology company that specialises in developing bespoke, peptide-based vectors for gene therapy. Nanogenics is proud to introduce LipTideTM; an exciting custom-built delivery vehicle that can be modified to target different cell types and deliver different payloads for all gene therapy. LipTideTM is a peptide nanoparticle that has already shown excellent in vivo efficacy across a range of models and delivery routes, including nebulised and systemic administration. The peptide component performs two functions: it binds the payload to form the core of the nanoparticle and it also triggers receptors on target cells, which cause the cell …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

0 0 0 1
StemTek Therapeutics StemTek Therapeutics

StemTek Therapeutics is a start-up biotechnolgy company dedicated to accelerating drug discovery in cancer using cutting edge technology, world-class science and a stem cell centric point of view for cancer therapy. Our mission is to help design novel treatments for cancer targeting cancer stem cells.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 1
TERRAMIE TERRAMIE

[Automatic translation follows] Terramie is the specialist in the creation of therapeutic gardens and gardens of life, throughout France. Our advisors support healthcare establishments and their teams in creating tailor-made gardens, adapted to structures and pathologies. For a long-lasting and vibrant living space, we also support caregivers in training specific to the Garden tool. Because the garden is known for its benefits for everyone's well-being, the Terramie team is committed to sharing its knowledge, with the help of health professionals, always in accordance with our ethics. Our charter is based on: - Respect for the person - Adapting the garden …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

1 0 0 1
Nano3D Biosciences Nano3D Biosciences

Nano3D Biosciences (n3D) is a biotechnology startup located in Houston, TX focused on 3D cell culture solutions for biomedical research, drug discovery, toxicology, precision medicine, and regenerative medicine. Our core technology, magnetic 3D bioprinting, works by magnetizing cells and aggregating them with magnetic forces into models that represent native tissue environments. The advantages of this platform over other 3D cell culture and bioprinting platforms are speed, ease, and handling. n3D offers products and services around this technology, with a worldwide distribution network, including an OEM partnership with Greiner Bio-One Cell culture, Assay development, 3D cell culture, Precision medicine, Toxicology, and …

Type: Startup Activities: biotech healthtech deeptech Technologies: 3D Printing Synthetic Biology

1 0 0 1
Drug and Alcohol Testing Institute (DAT Institute) Drug and Alcohol Testing Institute (DAT Institute)

Promote educational opportunities, advance "best practices," and benchmarking opportunities for DER's. Program Managers, Promoting a drug and alcohol-free workplace by advancing professionalism through quality education and best practices. Education, Networking, Regulatory Compliance, Drug Testing, Alcohol Testing, Safety, and Human Resources

Type: Startup Activities: entertainment Technologies: Synthetic Biology

2 0 2 1
Early Drug Development Group (E2DG) Early Drug Development Group (E2DG)

Boost your program in Oncology We offer professional support all along the drug development life cycle, from lead optimization to Phase I clinical trials in oncology. We optimize and accelerate your R&D programs, based on our drug positioning-oriented philosophy. Early Drug Development Group is focused on building partnerships and strategic alliances with academic research institutions, universities, governmental agencies, small size biotechnology partners and investment funds. COLLABORATION WITH US IMPROVES YOUR RESOURCES INVESTMENT AND STRENGTHENS YOUR EARLY DRUG DEVELOPMENT PROGRAM IN ONCOLOGY. YOUR KEY BENEFITS • Assistance on preclinical, pharmacological and CMC approaches, clinical studies design, regulatory strategies and trials implementation …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 1
MedNest MedNest

MedNest sources and develops the business of innovative Medical Technology companies for the US markets, with an exclusive focus in the Drug - Device & Diagnostic - Healthcare IT convergence space. MedNest offers Business and Clinical Operations services to companies looking for an experienced partner to operate their organic or inorganic growth projects, in particular during transition times (i.e. US Market Access preparation, deal search or post-acquisition integration), when execution risks and time to market must be minimal. Medical Devices, Convergent Medical Technologies, Medical Imaging, and Drug Delivery Systems

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

1 1 0 1
CEVIDRA NUCLEAR DECONTAMINATION CEVIDRA NUCLEAR DECONTAMINATION

CEVIDRA CREAM, THE EMERGENCY TREATMENT OF EXTERNAL RADIOLOGICAL AND NUCLEAR SKIN CONTAMINATION. WE SHARE WHAT WE LEARN. Skin contamination is one of the most probable risks in Nuclear Accidental Exposure with release of radioactivity. In this case whether it is major nuclear or radiological incident in Nuclear Power Plant, a Military submarine base, a Nuclear medicine department or a Dirty Bomb, general public, first responders, workers and soldiers will be exposed and contaminated. The possibility of accidents made the development of new decontamination strategies crucial. Cevidra, Pharmaceutical Laboratory, in collaboration with Institute for Radiological Protection and Nuclear Safety (IRSN-French national …

Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

0 0 0 1
Medical Device Guru LLC Medical Device Guru LLC

Medical Devices & Digital Health Consultant | Strategy, Commercialization, & Leadership | Serving Startups & Investors Medical Devices and Digital Health Consultant | Strategy, Commercialization, and Leadership Expert | Serving Startups, Investors, and Entrepreneurial Support Organizations If you have a medical technology invention or idea and need to know where to start, have launched into the marketplace and aren’t hitting your targets, or are most anywhere in between, you’ve come to the right place for expert medical device and digital health help. Whether it’s strategic direction, commercialization, fractional leadership or independent board representation, Medical Device Guru, LLC can help you …

Type: SMB Activities: deeptech healthtech constructiontech Technologies: Synthetic Biology

0 0 0 1
UrSure, Inc. UrSure, Inc.

UrSure makes patient-friendly diagnostic tests that measure and improve adherence to medications. UrSure makes urine tests to help doctors and patients improve medication adherence. We are initially focused on drugs to prevent and treat HIV infections. We have received over $2M in funding including winning the Harvard Business School's New Venture Competition and the Harvard President's Innovation Challenge as well as a Phase I and II SBIR from the NIH. We are currently working to scale up our lab based test, which is commercialized and on the market while we complete development of our Point of Care test which will …

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

0 0 0 1
Mighty Well Mighty Well

Mighty Well creates innovative products in the Adaptive Wear market, which is expected to reach $393B by 2026 (CBS News), for the 133 million Americans who live with a chronic condition. Mighty Well applies sportswear fabric technology to the medical industry and is building a digital supportive community of Friends in the Fight for our consumers. We are leading the global charge of helping patients and caregivers turn sickness into strength. Mighty Well was Co-Founded out of CEO, Emily Levy's, experience as a patient battling Lyme disease and living with long term medical devices.

Type: Startup Activities: healthtech fashtech Technologies: Synthetic Biology

4 1 4 1
AbiliLife AbiliLife

Join us on our mission to reduce back injuries and create a safer workforce with the Calibrace+ back brace. AbiliLife is a leading medical technology company transforming how people manage their mobility and balance challenges. Our innovative products are designed to enhance the quality of life and empower individuals to live independently and pain-free. Our flagship product, the Calibrace+, is a unique back brace that provides targeted support to the trunk and helps improve posture and balance. The Calibrace+ is a game-changer for workforces. Back injuries and pain are common problems in many industries, reducing productivity, absenteeism, and healthcare costs. …

Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology

0 0 0 1
GestSure GestSure

The GestSure System allows surgeons to control operating room computers while scrubbed using simple hand gestures. GestSure Technologies is creating rich, touchless gestural interfaces that allow surgeons and interventional radiologists to control the equipment around them. Our system works as a layer on top of existing PACS, 3D visualization, or electronic medical records. That means no clumsy software to install and no need to import imaging into a parallel system. Gestural Interfaces, Medical Devices, and Health IT

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

3 2 2 1
OSE Immunotherapeutics OSE Immunotherapeutics

Immuno-Oncology and Immuno-Inflammation - Breakthrough Immuno-Science for Patients OSE Immunotherapeutics is an integrated biotech company focused on developing first-in-class assets targeting cancer and inflammatory diseases. A current well-balanced first-in-class clinical pipeline including: • Tedopi® (T-cell specific immunotherapy): Company’s most advanced product; positive results for Ph 3 in NSCLC in secondary resistance after CKI failure. Other sponsored combo Ph 2 trials in solid tumors ongoing. • OSE-279 (anti-PD1) advanced preclinical stage • OSE-127 (humanized mAb antagonist of IL-7R); ongoing Ph 2 in Ulcerative Colitis; ongoing preclinical research in leukemia • VEL-101/FR104 (anti-CD28 mAb) developed in partnership with Veloxis in transplantation; ongoing …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

9 6 2 1
Vicept Therapeutics, Inc Vicept Therapeutics, Inc

Start-up Dermatology Company.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

11 1 0 1
Ecrins Therapeutics Ecrins Therapeutics

Ecrins Therapeutics is a biotechnology company which focuses on the discovery and development of novel anti-cancer compounds from the preclinical phase to phase II clinical proof of concept. In addition to the drug discovery, Ecrins Therapeutics provides a range of products and services for the benefit of our customers in biotechnology companies, universities, public research institutions and in the pharmaceutical industry. The mission of the commercial division of Ecrins Therapeutics is to help medical chemists and drug hunters to discover, characterize and advance their lead compounds through the drug development process. Visit http://ecrins-therapeutics-services.com/ for more information. Our research and production …

Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

2 0 2 1
NEOMED Services NEOMED Services

[Automatic translation follows] Your asset in design validation and regulation of medical devices

Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

0 0 0 1
Aureus Pharma Aureus Pharma

Aureus Sciences focuses on providing solutions to the needs of pharmaceutical and biotech companies to leverage information and knowledge as a decision making tool and to increase the speed and efficiency of their drug discovery and development process. Over the course of 10 years and with a significant investment, the Company has developed a unique Knowledge Production Platform which analyzes, indexes and organizes critical chemical and bioactivity information into databases. Using this platform the Company provides best-in-class, scientific databases and associated software applications for use by researcher involved in the drug discovery and development process.The company's range of products includes …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 1
INOVACTIS INOVACTIS

[Automatic translation follows] A versatile immunotherapy for personalized cancer medicine Inovactis is developing an innovative treatment against cancer on the border between several ongoing revolutions: individualized medicine, immunotherapy and synthetic biology. immunotherapy and personalized medicine

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 1
Unibiome (Peer To Peer Probiotics) Unibiome (Peer To Peer Probiotics)

Unibiome develops fermentative microbes that have been engineered to produce vitamins and other healthy compounds and designed to be used with any fermentation-based food to increase its nutritional value. We believe that re-purposing the food microbiome is a game-changing approach to feeding 9 billion people by 2050. Biotechnology, Synthetic Biology, Design, Microbiology, and Food Fortification

Type: Startup Activities: biotech foodtech Technologies: Synthetic Biology

0 0 0 1
Pharm'image Pharm'image

#Pharmaco-imaging, #nuclear medicine, #PET/MRI, #Radiochemistry, #Preclinical models Created in 2008 in Dijon, Pharm’image is a regional center of excellence in Pharmaco-imaging. Unique in France, it brings together hospitals, biotechnology, and pharmaceutical companies, to offer state-of-the-art of functional and molecular imaging technologies (MRI, PET, SPECT, CT), ranging from small-animal scale for preclinical experimentation to clinical exploitation Its aim is to deploy cutting-edge medical imaging technologies to evaluate biomarkers that can be used to track treatment efficacy and select the active and most promising drug candidates. imaging, preclinical evaluation, pharmacology, molecular imaging, nuclear medicine, radiochemistry, bioconjugation, translational research, in vivo pharmaco-imaging, First …

Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

0 0 0 1
In-Cell-Art In-Cell-Art

In-Cell-Art, is a biopharmaceutical company specializing in the preclinical and pharmaceutical development of solutions (DNA/RNA based vaccines or therapeutics) treating acquired or inherited diseases using patented bioinspired synthetic delivery systems (named Nanotaxi®) consisting of different chemical families (lipids, polymers). Its founder and research team, which includes a Nobel Laureate, have developed this unique intellectual property expertise and know-how based on 20 years of research in the field of supramolecular nucleic acids transfection agents. The vaccines and therapeutics developed by In-Cell-Art have been validated by numerous studies using infectious disease models (HIV, Flu, Dengue, dust mite, mycobacterium abscessus), therapeutic cancer models …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 1
Therapeutic Peptides, Inc. Therapeutic Peptides, Inc.

Therapeutic Peptides, Inc. is a research company based out of 11725Sun Belt Ct, Baton Rouge, Louisiana, United States.

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 1
Digital Ease® Digital Ease®

[Automatic translation follows] Facilitate access to digital through scalable rental You need to finance: > your computer equipment and software, > your video systems, > your communications and telephone equipment, > your medical or laboratory equipment, > your measuring instruments, > your robots and cobots, AGV, AMR, exoskeletons, > your industrial equipment, > your handling equipment, > ... Opt for financial leasing DIGITAL EASE facilitates companies' access to technological solutions thanks to scalable rental solutions adapted to both user companies and solution providers. DIGITAL EASE supports solution providers (manufacturers, distributors, software publishers, integrators, etc.) and in particular start-ups in setting …

Type: Startup Activities: IT Services Technologies: 3D Printing Robotics Synthetic Biology

6 1 5 1
MyCognition MyCognition

Changing the world one mind at a time MyCognition has developed NHS approved apps that assess and promote brain health through cognitive fitness. The apps are CE Marked (class 1A medical device) and recently we obtained a prestigious UCL award for our research. Our apps work on all devices, in all settings, are self-administrated and provide insightful reports and automatically assess to personalise cognitive training. They work in people of all ages, gender and health states. MyCognition enhances brain health and performance through the use of our cognitive fitness assessment and training programmes, which are self-administered, easy to access and …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

0 0 0 1
ArkAb ArkAb

ArkAb is now Bcell Design! ArkAb is now Bcell Design! Bcell Design develops and manufactures chimeric monoclonal antibodies with human-like characteristics for in vitro diagnostics. We provide a secure and reliable source of raw material as a best alternative to disease state plasma and human serum, currently used as calibrators, positive controls or quality controls. Through its technological platform, built upon 15 years’ expertise in mAb and early-stage immunotherapy development, IVD developers and manufacturers gain access to a wide range of antibodies that are immediately ready for testing in human models. Founded in 2007 and from one of the few …

Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

0 0 0 1
Synthesea Synthesea

Building a biological platform to produce low-cost, sustainable omega-3 for aquaculture. Powered by Synthetic Biology. Powered by Synthetic Biology, Synthesea is developing synthesis technology that is transferable to a wide range of lipids (AKA fats). And we're starting with omega-3. Omega-3 oil is a necessity for fish to grow nutritiously and is naturally found in algae, which wild fish eat. Fish grown in aquaculture (farms for fish livestock) cannot eat algae due to scaling limitations. Therefore, the current solution is to feed wild-caught fishmeal (crushed fish) to aquaculture fish. This rapidly depletes wild fish stocks and is continuously increasing the …

Type: Startup Activities: deeptech Technologies: Synthetic Biology

0 0 0 1
SmartBridge Health SmartBridge Health

cancer care as it should be Problem Statistically speaking, one in three people will have cancer in his or her lifetime. Moreover, according to the Journal of Clinical Oncology, up to 44% of cancer diagnoses and treatment plans are incorrect. If there’s any moment in your life when you want to be absolutely certain, it is when you are diagnosed with cancer. It can take weeks or months to reach an oncologist. Imagine the stress, worry and fear of trying to find the right information and the right oncologists when cancer cells are growing exponentially in your body. We have …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

0 0 0 1
Rahko Rahko

Part of Odyssey Therapeutics Rahko was acquired by Odyssey Therapeutics in 2021. Odyssey Therapeutics is a biotech company pioneering next gen immunomodulators and oncology medicine. Read more: https://odysseytx.com/news/

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

4 0 2 1
BrainPlotting BrainPlotting

Human PK data from preclinical stages BrainPlotting is a french contract research organization company which offers his knowledge to predict the entrance of drugs into the brain To that end BrainPlotting developped in vitro models based on fresh human tissus and cells. BrainPlotting is incubated at the Brain and Spine Institute (ICM), Paris, France Our core business is the study of pharmacokinetics (PK) in the human brain. The molecules that we study can have CNS targets as well as peripheral targets. To study the brain's PK, BrainPlotting uses the most accurate predictive models and the most recent methods and tools. …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 1
Platinum Informatics Ltd. Platinum Informatics Ltd.

Changing the world one experiment at a time. Platinum Informatics provides cloud-based software solutions which lay the foundations to manage big data and ensure reproducible results, whilst overcoming the challenges of remote working. With a focus on application in early-stage drug, vaccine and biomarker discovery in the growing area of precision medicine. Our vision is to build a world class Laboratory Informatics Company, that transforms scientific experimentation by bringing the digital laboratory of the future to the research laboratories of today.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 1
Sputnik V Sputnik V

The first registered vaccine against COVID-19 Sputnik V is the world’s first registered COVID-19 vaccine with proven 91.6% efficacy, based on a human adenoviral vector platform. Registered in over 70 countries.

Type: SMB Activities: deeptech Technologies: Synthetic Biology

4 0 1 1
LABORATOIRES CRYOBEAUTY PHARMA LABORATOIRES CRYOBEAUTY PHARMA

[Automatic translation follows] Permanently eliminates brown spots in just one application! Our company specializes in the research, development and fine-tuning of medical devices in dermatology and dermo-cosmetics using cutting-edge technology, unique in the world. This is Cyto-Selective Cryotherapy. This breakthrough technology is patented. It benefits from numerous competitive barriers. Cyto-Selective Cryotherapy consists of acting on the skin with controlled and perfectly controlled cold to target, for the first time, only cells according to their sensitivity and viability to temperature variations with extreme precision without affecting all the other cells of the skin. skin. After many years of research, we have …

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

0 0 0 1
AIOVA AIOVA

[Automatic translation follows] Vaccines for the future Based on innovative, patented technology, AIOVA aims to develop and market innovative vaccines, with high added value, to its pharmaceutical industrial clients. AIOVA is positioned in the fight against emerging or re-emerging and deadly pandemics of humans and animals, in a OneHealth approach, and in particular influenza (human and avian influenza), AIDS-type diseases, and, very recently , diseases caused by coronaviruses such as SARS-CoV-2, responsible for the current COVID-19 pandemic. The vaccines are designed using a patented DNA platform and have the properties of activating, in the vaccinated host, not only the production …

Type: Startup Activities: deeptech Technologies: Synthetic Biology

0 0 0 1
MV BioTherapeutics SA MV BioTherapeutics SA

A Microbiota biotherapeutics and Vaccines company A Swiss Microbiota biotherapeutics and Vaccines company, a spin-off from the Institute for Research in Biomedicine (IRB) in Bellinzona. The patent protected Apy platform is a unique mechanism to generate protective immune response against enteric infections and to shape the intestinal microbiota in medical conditions with two applications: 1. ApyraVax® with the lead indication of Clostridium difficile infection 2. ApyraMed® with lead indications as enhancer in cancer immunotherapy and modulator of antibiotic-induced disbyosis. Research experiments and preclinical trials are performed in the research lab hosted at IRB. The company is looking for seed funding …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 1 0 1
Myotact Myotact

Innovation for patient autonomy Myotact is a medical device that detects muscle activity by EMG and translates it into virtual movement with vibrotactile feedback.

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

23 5 22 1
Diagnostics For Animals Diagnostics For Animals

Federate and represent Manufacturers of Animal Health Diagnostics Promotes initiatives for the development of AHD Diagnostics For Animals is the only professional international #organization representing #animal #health #diagnostics. It federates and represents #manufacturers of animal health diagnostics at large, explains the benefit of an harmonized, efficient, and transparent regulatory framework to ensure the future #veterinary health industry and promotes initiatives for the development of animal health diagnostics health, animal, vet, veterinary, diagnostic, OneHealth, organization, livestock, pet, zoonosis, medical device, medical analysis, innovation, health security, research, and test

Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

1 0 0 1
MHW Care MHW Care

[Automatic translation follows] Lumix Laser - Cutting-edge technology - Unique, powerful & versatile Exclusive French distributor for FISIOLINE. Cutting-edge technologies and effective therapeutic protocols for results from the first session. Medical Device, Laser, and Surgery

Type: Startup Activities: healthtech Technologies: Synthetic Biology

1 1 0 1
Animal-Free Safety Assessment Collaboration Animal-Free Safety Assessment Collaboration

The AFSA Collaboration works to accelerate the adoption of modern, human-relevant approaches to testing. The Animal-Free Safety Assessment (AFSA) Collaboration is a unique multi-sector partnership between non-profit, corporate, and philanthropic leaders working to advance acceptance and use of animal-free safety science as a gold standard across regulatory frameworks worldwide. AFSA brings together corporate, philanthropic and non-profit leaders who share the goal of accelerating a modern, species-relevant approach to safety assessment globally to better protect people and our planet, and hasten the replacement of animal testing. Our members cooperate on a range of educational and policy topics specific to the cosmetics, …

Type: Startup Activities: deeptech Technologies: Synthetic Biology

5 1 5 1
KDBIO s.a.s. KDBIO s.a.s.

Distributor - cell culture products, hollow fiber cartridges KDBIO is actively seeking new life science distribution, sales and business development projects. Business Development, Sales, Marketing, and Distribution

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

0 0 0 1
AmyPore AmyPore

New target, new paradigm, new strategy that address the root cause of Alzheimer, Parkinson, and other proteinopathies AmyPore is a biotechnology company based around the leading science of Pr. Nouara Yahi (University of Aix-Marseillle) and Pr. Jacques Fantini (University of Aix-Marseille and Institut Universitaire de France). Their expertise in molecular neurosciences has led to the discovery of AmyP53, a first-in-class patented nontoxic molecule which tackles a common mechanism of neurotoxicity shared by Alzheimer and Parkinson diseases. The company applies its pioneering computational discovery platform coupled with high performance lipid-protein and protein-protein binding technology and ultrasensitive Ca2+ amyloid pore reporting assay …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 1
AbLeads AbLeads

AbLeads is a young biotech startup developing innovative solutions in Oncology, through the generation of novel, personalized therapeutic antibodies. Learn More on https://ableads.fr Biotechnology, Oncology, Immunotherapy, Therapeutic Antibodies, and Personalized Medicine

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

0 0 0 1
Synens Synens

Intelligent Drug Screening Synens is a French company that manufactures rapid on-site drug screening devices. We strive to deliver reliable and customizable drug test kits and analyzers. At Synens, adaptability is key. We meet the requirements of our clients and the regulations in force. Synens is the designer of the D1 Handheld Analyzer that is used internationally by law enforcement, fire departments, healthcare professionals and in workplaces. Technology, Drug Screening, and Drug of Abuse Detection

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

0 0 0 1
ONCOMECA ONCOMECA

Early diagnosis of skin cancers has never been that easy! ONCOMECA is a class IIb medical device according to the EU regulation 2017/745. Our technology lies in the identification of early skin cancers using their mechanical markers combined to their visual characteristics. Our expertise has been miniaturized and automatized to provide an easy-to-use and 90% reliable technology!

Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

0 0 0 1
Orio Therapeutics Orio Therapeutics

At Orio Therapeutics, our mission is to save lives by making the regenerative medicine dream accessible and a wide-spread reality. We are dedicated to developing novel regenerative drugs with increased efficacy and reduced side-effects, using cutting-edge targeted drug-delivery technologies to create novel therapeutic proteins. Notably, we strive to demonstrate that efficient drug delivery technologies are not confined to the development of complex devices and drug carriers but can be achieved based on clever molecular designs. We aim to initially validate our program pipeline through the development of a therapeutic molecule for myocardial infarction that has the potential to change the …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 1
MTInov MTInov

[Automatic translation follows] Scale-up platform for the production of innovative therapy drugs based on human cells or tissues. MTInov was born in 2020 from the association of the Cell Therapy Unit and Tissue Bank of the Nancy CHRU and the Bioprocesses Biomolecules research axis of the Reactions and Process Engineering Laboratory (CNRS, UL). This platform for studying, optimizing and scaling up the production of cell-based biomedicines, has expertise in cell culture in stirred bioreactors (online monitoring, intensification, modeling and design of bioreactors), as well as as in the transfer to clinical grade in accordance with good manufacturing practices.

Type: Public Activities: deeptech biotech Technologies: Synthetic Biology

2 2 0 1
Biossan Biossan

your partner for preclinical research Biossan : A French CRO dedicated to biomedical research Biossan helps its academic and industrial partners develop their innovations by performing preclinical trials under controlled conditions. Biossan specializes in evaluating medical devices, new techniques, and pharmaceutical products in healthy and pathological models. Conduite et accompagnement de projet de recherche, Organisation de formation, and Bien-être et expérimentation animale

Type: Startup Activities: deeptech Technologies: Synthetic Biology

1 1 0 1
REALETEE REALETEE

[Automatic translation follows] Custom-made external breast prosthesis. 3D medical device to identically replace the breast after breast cancer Custom-made external breast prosthesis. breast prosthesis, external prosthesis after breast cancer, 3D scanning, 3D printing, and CAD

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

1 1 0 1
Diotheris Diotheris

Diotheris develops anti-infective microbes to prevent bacterial infections and act against antibiotic resistance We create bacterial therapies of the human skin and mucosal microbiome against pathogenic bacteria. Our first suite of products (NASOFLORE line) targets Staphyloccocus aureus / MRSA (Methicillin resistant S aureus). The products based on live bacteria identified in our clinical and in vitro studies do not generate emergence of antibiotic resistance. antimicrobial, nose microbiome, therapeutics, LBP, Staphylococcus Aureus, and MRSA

Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

1 1 0 1
MolDrug MolDrug

Chemoinformatics and modeling solutions to optimize your drug candidates. MolDrug is a company group specialized in the design and optimization of molecules through Machine Learning-powered chemoinformatics and structural bioinformatics. Our models allow for the prediction of molecular properties (QSAR) and detailed interaction analyses (molecular modelling). We work with all types of compounds, including small molecules, peptides, nanomaterials, mixtures... Our tools allow for the prediction and assessment of physicochemical, biological, pharmacological, and/or (eco)toxicological properties of substances with an array of advantages: - faster results - saving money and resources - reduce animal testing (3 Rs) - regulatory validity (REACH, CLP, ICH, …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

0 0 0 1
GCS ACHATS NOUVELLE AQUITAINE GCS ACHATS NOUVELLE AQUITAINE

[Automatic translation follows] Coordination of regional purchasing for health, social and medical-social establishments. 🏆♻ 2023_ Winner of the Purchasing Strategy Prize and implementation of CSR in purchasing. [Purchasing Crystal] Coordination of regional purchasing for health, social and medical-social establishments Purchasing, Medical devices, Medicines, Maintenance of premises, Food, Helicopter medical transport, Textiles, DASRI, and Periodic technical inspections

Type: SMB Activities: healthtech Technologies: Synthetic Biology

4 4 1 1
ECOVO ECOVO

Project manager within medical device and pharmaceutical industry.

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

0 0 0 2
Alzohis Alzohis

Entreprise de dispositif médical de diagnostic in vitro : Noratest® In vitro diagnostic medical device Diagnostic, Innovation, Maladies neurodégénératives, Alzheimer, Neurosciences, Entreprise, and Entrepreneuriat

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

1 0 1 2
MaxBionic MaxBionic

We develop prosthetic technologies transforming the market. Our goal is to help rehabilitate after amputation using technology. Solutions are available for those who have suffered amputation of the upper extremities. MaxBionic is a young company specializing in prosthetics that drastically transforms the market through its technologies. At present, one can choose from available products for use after upper limb amputation. Our task is to increase, by using the latest technologies, the rehabilitation efficiency in people after amputation. Robotic, Medicine, Prosthetic, Rheabilitation, and manufacture

Type: Startup Activities: deeptech healthtech manufacturing Technologies: Robotics Synthetic Biology

0 0 0 2
Bitome Bitome

Better tools, faster science Bitome is a Boston-based life sciences tools company that uses metabolomic insights to drive efficient biomanufacturing. Bitome's magnetic-resonance/neural-network-driven platform provides quantified analysis of the cell culture environment -- enabling bio-based products to get to market faster. Our mission at Bitome is to enable the bioeconomy with purpose made tools, so join us as we de-risk industrial biology. Magnetic Resonance, synthetic biology, continuous monitoring, metabolic analysis, lab automation, instrumentation, MEMS, microfluidics, and machine learning

Type: Startup Activities: deeptech biotech Technologies: A.I. A.I. - Machine Learning Bio sourced materials Synthetic Biology

0 0 0 2
BRAINCURES BRAINCURES

Powering a drug discovery revolution to deliver cures for brain diseases that affect at least 1 in 10 people worldwide Brain diseases have no cures and affect 1 in 10 people worldwide and their families. BRAINCURES aims to tackle brain diseases with precision medicine based on the code for brain function. Our landmark decoding of the molecular framework behind brain health pinpointed SMART Target-Biology linkages that now empower novel translational avenues to conquer brain diseases through SMART Patient Stratification and SMART Treatments. The application of our proprietary platform technologies will lead to personalized treatments for the 350 million people worldwide …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

0 0 0 2
ElyssaMed SAS ElyssaMed SAS

ElyssaMed® will develop the first therapeutic treatment for clinical use comprising several antigenic peptides (epitopes) derived from CTPP and selective for non-small-cell lung cancer, combined with an already marketed vaccine adjuvant. This product once administered to lung cancer patients, will amplify the patients' specific immune responses against tumor cells expressing the antigen CTPP and lead to their destruction.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

4 4 0 2
9th Dimension Biotech, Inc. 9th Dimension Biotech, Inc.

Planting the seeds of human health. PLANTING THE SEEDS OF HUMAN HEALTH. First in the world to offer the age-reversing, lifespan and healthspan enhancing Osmotin plant protein product line. Available now in the US and worldwide. Visit www.osmotin.com for more info. biotech, cell life and death cycle, plant biotechnology, human health, age-reversing, and agriculture

Type: Startup Activities: biotech deeptech agritech Technologies: Synthetic Biology

0 0 0 2
ADEXSOL ADEXSOL

Adexsol is a consulting and training company based in Paris that provides healthcare companies and institutions with knowledge of the goals, organisation and functioning of the French healthcare system. Adexsol can help you with: - Better understanding and analysing needs of the hospital and healthcare world in order to build an offer meeting key players’ needs. - Setting up training for industry sales forces and managers on topics related to organisation and functioning of the hospital. - Carrying out market research, polls and opinion trackers. - Organising events nationally or regionally: conferences, workshops, seminars, and scientific boards. - Developing your …

Type: Startup Activities: healthtech martech Technologies: Synthetic Biology

4 0 2 2
Biogelx Biogelx

We design and supply artificial tissue environments for cell culture & bioprinting applications. Biogelx is helping people work in translational science, drug discovery and tissue engineering by 'making in vitro cell cultures more in vivo'​. We do this through manufacturing and supplying 3D cell cultures that can be tuned to specific tissues and synthetic bio-inks that are reproducible, scalable, easy to handle and suitable for clinical decision making. Our portfolio of biomaterials is comprised of synthetic peptide hydrogels that act as extracellular-matrix environments to support cell growth. In addition, the chemical and physical properties of our biomaterials can be precisely …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

2 0 0 2
Coral Biome PHARMA Coral Biome PHARMA

CORAL BIOME PHARMA Live cultured corals for Drug discovery Coral Biome is a research and development company dedicated to the discovery of marine natural products of interest for major public health issues such as cancer, inflammation and multi-drug resistant infectious diseases. Our multidisciplinary team of research and worldwide network of collaborators gathers a unique set of competitive expertise including, aquaculture, marine biology, chemistry, cell biology and cancerology to successfully isolate marine natural products and test their biological activity. We maintain a large-scale untapped reservoir of coral species to preserve endangered species, sell corals for aquarium trade (http://www.coralbiome.com/aquaculture/) and provide research …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 2
WHEYD WHEYD

Stomach-friendly Protein Powders Designed for Elite Level Athletes To Improve Performance and Recovery. Simply put, our whey is different to the rest, as is the way we do business and work with suppliers & amazing customers. We provide the highest quality, stomach-friendly, Irish whey protein in delicious flavours, both in single-serve sachets and larger bags. We help those looking to increase their protein intake (20g per portion), while keeping their fat and sugar intake low. By providing the lowest calorie whey protein (86 calories a portion), sustainably sourced from Irish dairy cows, we aim to revolutionise the world of whey …

Type: Startup Activities: healthtech sporttech Technologies: Synthetic Biology

0 0 0 2
Repositive Repositive

Accelerating biomedical research by connecting biopharmas with the right preclinical cancer models and CRO partners Repositive is committed to accelerating the development of precision cancer therapies to the clinic by working with biopharmas and Contract Research Organisations (CROs) to improve the predictivity of pre-clinical cancer research. Through its Cancer Models Scout service, Repositive is helping biopharmas to optimise their pre-clinical cancer projects by identifying the most suitable cancer models for their requirements from its world-leading database of over 8000 models, as well as via outreach to an extended network of CRO contacts. Repositive works to connect researchers with the right …

Type: Startup Activities: biotech deeptech IT Services Technologies: Synthetic Biology

5 2 3 2
Casebia Therapeutics Casebia Therapeutics

An innovative gene editing company discovering and developing curative treatments for genetic diseases Bayer and CRISPR Therapeutics have entered into an agreement to create Casebia to discover, develop and commercialize new breakthrough therapeutics to cure blood disorders, blindness, and congenital heart disease. CRISPR Therapeutics will contribute its proprietary CRISPR-Cas9 gene-editing technology and intellectual property, while Bayer will make available its protein engineering expertise and relevant disease know-how. It is the first long-term strategic partnership of its kind to make a substantial investment in the development of target delivery systems in an effort to bring systemic in vivo CRISPR-Cas9 gene editing …

Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology

0 0 0 2
NeurologyLive NeurologyLive

Neurology Live is your trusted news source for breaking drug approvals, pipeline trials and emerging trends in neurology. The digital and print publication provides physicians and other healthcare professionals with up-to-date disease-specific news, clinical information and other resources that can help them provide better care to patients. At Neurology Live, you'll find in-depth conference coverage and information about upcoming meetings, content from our affiliated print journals, video interviews with leading physician experts and other multimedia resources. Get all the latest news on individual medical conditions in our condition centers: • Dementia & Alzheimer Disease • Epilepsy • Headache & Migraine …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

4 0 4 2
Luxia Scientific Luxia Scientific

New generation microbiome diagnostics for personalised medicine Luxia Scientific is a french start-up company, leading the next wave of breakthrough personalized diagnostics. The company was started by Alessandra Cervino, former research director at Enterome. Luxia scientific is pioneering the development of novel diagnostics based on the genetic analysis of microbiomes. The company has brought to the market it’s first test in Q4 2018 and is developing two additional diagnostics. The Company is affiliated to Medicen and is supported by the BPI, Region Ile de France. Statistics, Biomarkers, Statistical genetics, qPCR, genetics, genomics, microbiome, metagenomics, nutrition, well being, health, probiotics, prebiotics, …

Type: Startup Activities: biotech deeptech healthtech Technologies: Data Analytics Synthetic Biology

3 2 0 2
Medsteer Medsteer

Medsteer, with offices in Paris/France (HQ) and New York/USA, is a leading technology provider in the field of closed loop systems for the delivery of anaesthesia drugs. The company’s patented technologies focus on drug delivery solutions guided by the cortical activity of the patient. Medsteer’s proprietary closed loop anesthesia technology (“EasyTIVA”) has been successfully tested in 25 multicenter clinical trials, representing 11 000 patient inclusions, 150 anesthesiologists and 50 operating rooms in Europe since 2003. Providing full automation and customization to the individual patient’s needs, closed loop anaesthesia opens up the way to a wide array of patient benefits associated …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

0 0 0 2
SMICES SURGICAL SMICES SURGICAL

You take care of others, we take care of you. SMICES is a european company based in Montpellier, which offers innovative, smart, and effective solutions, to the challenges encountered in the medical and surgical field. SMICESs commitment: improve the well-being of surgical teams and the safety in the operating theatre, in order to provide better patient care. SMICES works side by side with surgeons to develop the best medical devices, suitable for use in the operating room. For some years, the problem of the surgical smoke hazards during laparoscopy is raised. These smokes contain harmful substances and cause visual and …

Type: SMB Activities: healthtech Technologies: Synthetic Biology

1 0 0 2